HeartBeam, Inc.

Análisis de la acción HeartBeam, Inc. (BEAT)

$0.406

+0.011 (+2.74%)Al cierre

Loading chart…
Máximo
0.413
Apertura
0.395
Precio medio ponderado por volumen
0.40
Volumen
817.90K
Capitalización
66.09M
Mínimo
0.382
Importe
327.05K
EV/EBITDA, TTM
0.00

HeartBeam, Inc. is a cardiac technology company. The Company focuses on developing and commercializing higher resolution ambulatory Electrocardiogram (ECG) solutions that enable the detection and monitoring of cardiac disease both inside and outside a healthcare facility setting. It is engaged in the development of higher resolution ECG solutions is achieved through the development of the Company’s proprietary and patented electrocardiography technology platform. It is developing three-dimensional (3D) representations of cardiac electrical activity by displaying the spatial locations of ECG waveforms. It is developing its own product, the HeartBeam System. The HeartBeam System comprises a credit card sized 12-lead output electrocardiogram device, a patient application, a physician portal, and powerful cloud-based algorithms. The core technology consists of a series of patented inventions that allow it to capture the heart’s electrical activity from three distinct directions.

www.heartbeam.com

Análisis de IA of HeartBeam, Inc. (BEAT)

Vender

HeartBeam Inc. is not a good buy right now due to significant ongoing losses and a declining stock price. The current price is $0.41, which is 83.31% lower year-to-date. The RSI is at 39.643, indicating the stock is nearing oversold territory, but the negative sentiment and financial performance overshadow this. The company reported a net loss of $4.7 million in Q1 2026, and the forward P/E ratio is 0, indicating no earnings expected in the near future. The main risk is the high volatility, with a 5-day change of -26.27%.

Recomendaciones de analistas (7)

+1337.73% de potencial alcista
Comprar
7 Comprar
0 Mantener
0 Vender
Actual: 0.41
Mínimo
4.00
Promedio
5.83
Máximo
8.00

H.C. Wainwright

2026-09-22

Precio objetivo

—

Neutral

Maxim

2026-07-14

Precio objetivo

$2

Comprar

Benchmark

2026-05-15

Precio objetivo

$5

Speculative Buy

D. Boral Capital

2026-04-20

Precio objetivo

—

Mantener

Roth Capital

2025-10-31

Precio objetivo

$4

Comprar

Métricas de valoración

El PER previsto actual de HeartBeam, Inc. (BEAT) es 0.00, frente a su media de 5 años de -2.80.

PER previsto

Muy sobrevalorado
Media 5A P/E
-2.80
P/E actual
0.00
Sobrevalorada
-1.46
Infravalorada
-4.15

EV/EBITDA previsto

Valor razonable
Media 5A EV/EBITDA
-0.14
EV/EBITDA actual
0.00
Sobrevalorada
0.44
Infravalorada
-0.72

Precio/ventas previsto

Valor razonable
Media 5A P/S
72.96
P/S actual
5.95
Sobrevalorada
333.41
Infravalorada
-187.48

Escenarios de precio de Alphio AI para BEAT

Los precios por escenario son la última banda de previsión mensual del año en curso. Las probabilidades son pesos fijos del modelo (25 / 50 / 25), no garantías.

A

Alcista

Alcista · 25%BEAT

$1.70

Precio del escenario

B

Base

Base · 50%BEAT

$1.50

Precio del escenario

B

Bajista

Bajista · 25%BEAT

$1.28

Precio del escenario

Cronología de eventos

2026-11-02 (ET)

09:00:00

HeartBeam Announces Positive Results from ALIGN-ACS Study

2026-10-28 (ET)

09:31:00

HeartBeam to Present Heart Attack Study Results at TCT 2026

2026-10-26 (ET)

09:00:00

HeartBeam's 3D ECG Technology Accepted into FDA TAP Program

2026-10-05 (ET)

09:00:00

HeartBeam Receives FDA Breakthrough Device Designation

2026-09-21 (ET)

09:00:00

HeartBeam Clarifies Focus on Heart Attack Detection

Noticias

Preguntas frecuentes sobre BEAT, respondidas por Alphio AI

HeartBeam, Inc. is a cardiac technology company. The Company focuses on developing and commercializing higher resolution ambulatory Electrocardiogram (ECG) solutions that enable the detection and monitoring of cardiac disease both inside and outside a healthcare facility setting. It is engaged in the development of higher resolution ECG solutions is achieved through the development of the Company’s proprietary and patented electrocardiography technology platform. It is developing three-dimensional (3D) representations of cardiac electrical activity by displaying the spatial locations of ECG waveforms. It is developing its own product, the HeartBeam System. The HeartBeam System comprises a credit card sized 12-lead output electrocardiogram device, a patient application, a physician portal, and powerful cloud-based algorithms. The core technology consists of a series of patented inventions that allow it to capture the heart’s electrical activity from three distinct directions. It operates in the Healthcare sector (SURGICAL & MEDICAL INSTRUMENTS & APPARATUS industry).

HeartBeam Inc. is not a good buy right now due to significant ongoing losses and a declining stock price. The current price is $0.41, which is 83.31% lower year-to-date. The RSI is at 39.643, indicating the stock is nearing oversold territory, but the negative sentiment and financial performance overshadow this. The company reported a net loss of $4.7 million in Q1 2026, and the forward P/E ratio is 0, indicating no earnings expected in the near future. The main risk is the high volatility, with a 5-day change of -26.27%.

7 analysts cover BEAT: 7 rate it Buy, 0 Hold and 0 Sell. The average price target is 5.83.

Comunidad

Más ↗

Good fortune and great times. Fish for dinner tonight. Brothers, it's time for dinner. $ETH $ZEC $AKE #USOctoberNonfarmPayrollsBeatExpectations, DecemberRateHikeBetsRise

Mostrar más
HyperTraderhace 13 h

500 Yuan Challenge to Reach 100 Million! Day 44 Principal 500 yuan, goal 100 million Current: 10,707 yuan Living costs: 5,000 yuan Available funds: 5,707 yuan The Big Devil 500-to-100-million live trading progress! First, the account: total assets 5,707.3 yuan, monthly return directly 81.1%, profit 2,873 yuan. This equity curve is really worth watching. It once peaked at 8,773, then heavily drawdown to 505, almost back to the initial principal. After enduring a wave of extreme shakeout, it walked back up again. This time I positioned two 10x short orders on $CAP and $BEAT, both showing unrealized gains. The CAP short was opened at 0.10358, unrealized gain close to 28%; the BEAT short was opened at 0.10839, unrealized gain nearly 50%. Margin is sufficient, and the safety distance is ample. Looking back at the chart, both are small-cap new coins. After an earlier surge, bullish momentum faded, overhead selling pressure kept releasing, and prices gradually pulled back, which fit our idea of testing shorts at highs. But the biggest feature of small-cap coins is that funds can push them up at any time, and a single big green candle can reverse everything, so I must not get carried away. The plan going forward is clear: don't be greedy. Move take-profit levels up and lock in part of the profit first. Focus on the overhead resistance. Once price holds above resistance, it means the short-term trend has reversed, so reduce the position and exit immediately. The challenge road is long. In such highly volatile coins, surviving first and protecting profit is what gives me the chance to slowly move toward 100 million! The 500 yuan challenge to reach 100 million was never about stable, effortless gains. It is a process of constant trial, review, and risk control. Don't get proud when profitable, summarize lessons when losing, strictly control leverage and position size, and move step by step toward the goal. $BTC #US October nonfarm payrolls beat expectations, December rate hike bets rise #US stocks rebound in tech after selloff, Nasdaq still down about 3.4% for the week #BTC and ETH spot ETFs see over $1.6 billion in net outflows for the week

Mostrar más
rhocurrent1/11/2026

I couldn't resist shorting $BEAT on the left side again, entered at 0.103. The hardest part of holding was when I was down -600u, price had risen to 0.11. Now it's a bit better, back to 0.104. Should I take the loss and exit, or keep holding?

Mostrar más
CopperBaker31/10/2026

$BEAT Although the 17.63M BEAR unlock is happening tomorrow, I still wouldn't recommend holding a heavy position right now. Everyone knows the market maker tends to push the price up before an unlock to sell off. There was already a pump earlier, and many people assume it's a safe short here. But this kind of mid-range price action right before an unlock is the most dangerous. A bearish view is reasonable, but the biggest risk is a violent pump before the dump that squeezes out shorts and then drags longs down with it, letting them capture both sides. Not holding heavy is what keeps your position able to withstand a sharp pump from the market maker. If you want to be cautious, you can enter short in the early morning or on a bounce near 0.1-0.11. You can also enter at the current price of 0.096, but start light and keep room to add.

Mostrar más
Regístrate o inicia sesión para participar

Artículos relacionados

Esta página es solo para investigación y no constituye asesoramiento de inversión. Los modelos pueden equivocarse. El rendimiento pasado no garantiza resultados futuros.

Empezar a operar